Recently, there is an increasing trend concerning the exosome nanotechnology [ 26 ].
← all excerpts
Downregulated exosome-associated gene FGF9 as a novel diagnostic and prognostic target for ovarian cancer and its underlying roles in immune regulation.
1
—
—